Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor α neutralization

Tumor Necrosis Factor, but Not Neutrophils, Alters the Metabolic Profile in Acute Experimental Arthritis

(2016) Marina C. Oliveira et al.   PLoS One

Quantitative dynamic imaging of immune cell signalling using lentiviral gene transfer

(2015) J. Bagnall et al.   Integrative Biology

Effects of anti-inflammatory therapy on bursting pressure of colonic anastomosis in murine dextran sulfate sodium induced colitis

(2015) Pär Myrelid et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation

(2014) Melanie Timmen et al.   BMC MUSCULOSKELETAL DISORDERS

Tumor Necrosis Factor Is a Therapeutic Target for Immunological Unbalance and Cardiac Abnormalities in Chronic Experimental Chagas’ Heart Disease

(2014) Isabela Resende Pereira et al.   MEDIATORS OF INFLAMMATION

Locally injected Infliximab ameliorates murine DSS colitis: Differences in serum and intestinal levels of drug between healthy and colitic mice

(2013) Loris Riccardo Lopetuso et al.   DIGESTIVE AND LIVER DISEASE

The renal injury and inflammation caused by ischemia–reperfusion are reduced by genetic inhibition of TNF-αR1: A comparison with infliximab treatment

(2013) Rosanna Di Paola et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Mechanisms of Action of Anti–tumor Necrosis Factor α Agents in Crohn’s Disease

(2013) Simon T. C. Peake et al.   INFLAMMATORY BOWEL DISEASES

The role of TNF-α in a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide

(2013) Toshiaki Oharaseki et al.   Modern Rheumatology

Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels

(2012) L. Semerano et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

RETRACTED: Obesity-Induced Increase in Tumor Necrosis Factor-α Leads to Development of Colon Cancer in Mice

(2012) Marcelo B.S. Flores et al.   GASTROENTEROLOGY

Infliximab and Etanercept Are Equally Effective in Reducing Enterocyte APOPTOSIS in Experimental Colitis

(2012) Walter Fries et al.   International Journal of Medical Sciences

Inactivation of TNF-α ameliorates diabetic neuropathy in mice

(2011) Isamu Yamakawa et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice

(2011) Wei Qiu et al.   JOURNAL OF CLINICAL INVESTIGATION

Interplay between TNF and Regulatory T Cells in a TNF-Driven Murine Model of Arthritis

(2011) Jérôme Biton et al.   JOURNAL OF IMMUNOLOGY

The Combination of a Tumor Necrosis Factor Inhibitor and Antibiotic Alleviates Staphylococcal Arthritis and Sepsis in Mice

(2011) Ying Fei et al.   JOURNAL OF INFECTIOUS DISEASES

Mammalian Genes Are Transcribed with Widely Different Bursting Kinetics

(2011) D. M. Suter et al.   SCIENCE

Prevention of Colitis-Associated Carcinogenesis with Infliximab

(2010) Y. J. Kim et al.   Cancer Prevention Research

Anti-tumor necrosis factor α treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C

(2010) Erwin Daniel Brenndörfer et al.   HEPATOLOGY

Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls

(2010) Léia CR Silva et al.   Immunotherapy

Colonic transcriptional profiling in resistance and susceptibility to trichuriasis

(2010) S. E. Levison et al.   INFLAMMATORY BOWEL DISEASES

Treatment of experimental colitis in mice with LMP-420, an inhibitor of TNF transcription

(2008) Laura P Hale et al.   Journal of Inflammation-London